Genetic Mechanisms in Interval Colon Cancers-Reference-Cited by-同舟云学术

Genetic Mechanisms in Interval Colon Cancers

Published:2014-04-05 Issue:9 Volume:59 Page:2255-2263
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Richter James M.,Pino Maria Simona,Austin Thomas R.,Campbell Emily,Szymonifka Jackie,Russo Andrea L.,Hong Theodore S.,Borger Darrell,Iafrate A. John,Chung Daniel C.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-014-3134-2.pdf

Reference33 articles.

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.

2. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573.

3. Pignone M, Rich M, Teutsch S, Berg A, Lohr K. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.

4. Smith R, Cokkinides V, Brawley O. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41.

5. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–560.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and molecular differences between stage IV screen-detected and interval colorectal cancers in the Flemish screening program;Frontiers in Oncology;2024-09-02

2. Proportions and characteristics of interval cancer in annual fecal immunochemical test screening and postcolonoscopy colorectal cancer: Results from a Japanese multicenter prospective study using questionnaires, the C‐DETECT study;Digestive Endoscopy;2024-03-03

3. Mucin 5AC is a sensitive surface marker for sessile serrated lesions: results from a systematic review and meta-analysis;2024-02-13

4. ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing;Frontiers in Oncology;2022-03-23

5. Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective;British Journal of Cancer;2022-01-12